01.08.25 -- What's Needed To Transform Clinical Trials In Early-Stage Prostate Cancer

Biopharma companies and CROs can utilize real-world data to better reflect real-world populations in clinical trials, optimizing protocol design,site selection, and patient matching.

The global vaccine trial landscape is undergoing rapid evolution, driven by technological innovations, emerging health threats, and regulatory shifts.

What role does Good Clinical Practice (GCP) play in the clinical research ecosystem and how does it safeguard participant rights, safety, and confidentiality while fostering compliance?

Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.

Stem cell therapy has already revolutionized the field of oncology. But where do we go from here? Dr. Robert S. Negrin addresses three key areas of CAR T-cell therapy on the brink of innovation.

Uncertainty is inherent in clinical research. Uncover new strategies and solutions to alleviate risk so clinical teams can confidently and quickly bring products to market.

Connect your clinical program with strong scientific and medical expertise, deep therapeutic insights, and unrivaled experience to find a direct route from breakthrough science to new therapies. 

Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.

Learn about innovative, portable, battery-operated ECG technology that helps you address traditional challenges such as misplaced leads, patient discomfort, and spatial limitations.